% Expired Patents = 40.0

Trademarks = 7

Forward Citations = 152

Loading Chart...

7 inventors (with patents filed for the assignee):

Abu Alam (3 out of 7 patents)

Robert W Flower (2 out of 21 patents)

Biswajit Pati (2 out of 2 patents)

4. Saeed U Khan (1 out of 1 patent)

5. Elias Reichel (1 out of 5 patents)

6. Sean E Brynjelsen (1 out of 1 patent)

7. Brandon Busbee (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 10426834 - Methods of sterilizing drugs (2019-10-01),

2. 9517269 - Stable pentobarbital formulation (2016-12-13),

3. 8759401 - Aqueous gel formulation and method for inducing topical anesthesia (2014-06-24),

4. 6443976 - Methods for treating conditions and illnesses associated with abnormal vasculature (2002-09-03),

5. 6351663 - Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation (2002-02-26),

Company Overview

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. The company's products are used in a wide range of therapeutic areas including ophthalmology, dermatology, pain management, and respiratory. Akorn's mission is to provide high-quality, affordable medicines to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#35 in Lake Forest, IL

#2,422 in Illinois

#51,570 in US

Lake Forest, IL, United States of America

Akorn, Inc.

Forward Citations = 152

7 inventors:

Abu Alam (3 out of 7 patents)

Robert W Flower (2 out of 21 patents)

Biswajit Pati (2 out of 2 patents)

4. Saeed U Khan (1 out of 1 patent)

5. Elias Reichel (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akorn, Inc.. Retrieved from https://idiyas.com/company/akorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]